210 related articles for article (PubMed ID: 33809385)
1. Development and Translation of NanoBEO, a Nanotechnology-Based Delivery System of Bergamot Essential Oil Deprived of Furocumarins, in the Control of Agitation in Severe Dementia.
Scuteri D; Cassano R; Trombino S; Russo R; Mizoguchi H; Watanabe C; Hamamura K; Katsuyama S; Komatsu T; Morrone LA; Rombolà L; Adornetto A; Laganà AS; Corasaniti MT; Tonin P; Sakurada S; Sakurada T; Nicotera P; Bagetta G
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33809385
[TBL] [Abstract][Full Text] [Related]
2. Requirements for Translation in Clinical Trials of Aromatherapy: The Case of the Essential Oil of Bergamot (BEO) for Management of Agitation in Severe Dementia.
Scuteri D; Sakurada S; Sakurada T; Tonin P; Bagetta G; Nicotera P; Corasaniti MT
Curr Pharm Des; 2022; 28(20):1607-1610. PubMed ID: 35579159
[TBL] [Abstract][Full Text] [Related]
3. Bergamot rehabilitation AgaINst agitation in dementia (BRAINAID): Study protocol for a randomized, double-blind, placebo-controlled trial to assess the efficacy of furocoumarin-free bergamot loaded in a nanotechnology-based delivery system of the essential oil in the treatment of agitation in elderly affected by severe dementia.
Scuteri D; Sandrini G; Tamburin S; Corasaniti MT; Nicotera P; Tonin P; Bagetta G
Phytother Res; 2021 Oct; 35(10):5333-5338. PubMed ID: 34435395
[TBL] [Abstract][Full Text] [Related]
4. Analgesic Characteristics of NanoBEO Released by an Airless Dispenser for the Control of Agitation in Severe Dementia.
Scuteri D; Rombolà L; Hayashi T; Watanabe C; Sakurada S; Hamamura K; Sakurada T; Tonin P; Bagetta G; Morrone LA; Corasaniti MT
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956935
[TBL] [Abstract][Full Text] [Related]
5. Neuropharmacological Properties of the Essential Oil of Bergamot for the Clinical Management of Pain-Related BPSDs.
Scuteri D; Rombolá L; Tridico L; Mizoguchi H; Watanabe C; Sakurada T; Sakurada S; Corasaniti MT; Bagetta G; Morrone LA
Curr Med Chem; 2019; 26(20):3764-3774. PubMed ID: 29521195
[TBL] [Abstract][Full Text] [Related]
6. Neuropharmacology of the Neuropsychiatric Symptoms of Dementia and Role of Pain: Essential Oil of Bergamot as a Novel Therapeutic Approach.
Scuteri D; Rombolà L; Morrone LA; Bagetta G; Sakurada S; Sakurada T; Tonin P; Corasaniti MT
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284573
[TBL] [Abstract][Full Text] [Related]
7. Rational Basis for the Use of Bergamot Essential Oil in Complementary Medicine to Treat Chronic Pain.
Rombolà L; Amantea D; Russo R; Adornetto A; Berliocchi L; Tridico L; Corasaniti MT; Sakurada S; Sakurada T; Bagetta G; Morrone LA
Mini Rev Med Chem; 2016; 16(9):721-8. PubMed ID: 26996621
[TBL] [Abstract][Full Text] [Related]
8. Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa.
Ballard CG; O'Brien JT; Reichelt K; Perry EK
J Clin Psychiatry; 2002 Jul; 63(7):553-8. PubMed ID: 12143909
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive effect of inhalation of the essential oil of bergamot in mice.
Scuteri D; Crudo M; Rombolà L; Watanabe C; Mizoguchi H; Sakurada S; Sakurada T; Greco R; Corasaniti MT; Morrone LA; Bagetta G
Fitoterapia; 2018 Sep; 129():20-24. PubMed ID: 29906556
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms Underlying the Anti-Inflammatory Activity of Bergamot Essential Oil and Its Antinociceptive Effects.
Lombardo GE; Cirmi S; Musumeci L; Pergolizzi S; Maugeri A; Russo C; Mannucci C; Calapai G; Navarra M
Plants (Basel); 2020 Jun; 9(6):. PubMed ID: 32492797
[TBL] [Abstract][Full Text] [Related]
11. Preclinical Characterization of Antinociceptive Effect of Bergamot Essential Oil and of Its Fractions for Rational Translation in Complementary Therapy.
Scuteri D; Rombolà L; Crudo M; Watanabe C; Mizoguchi H; Sakurada S; Hamamura K; Sakurada T; Tonin P; Corasaniti MT; Bagetta G
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214045
[TBL] [Abstract][Full Text] [Related]
12. Bergamot Essential Oil Attenuates Anxiety-Like Behaviour in Rats.
Rombolà L; Tridico L; Scuteri D; Sakurada T; Sakurada S; Mizoguchi H; Avato P; Corasaniti MT; Bagetta G; Morrone LA
Molecules; 2017 Apr; 22(4):. PubMed ID: 28398260
[TBL] [Abstract][Full Text] [Related]
13. A controlled trial of aromatherapy for agitation in nursing home patients with dementia.
Snow LA; Hovanec L; Brandt J
J Altern Complement Med; 2004 Jun; 10(3):431-7. PubMed ID: 15253846
[TBL] [Abstract][Full Text] [Related]
14. Using Complementary and Alternative Medicine to Treat Pain and Agitation in Dementia: A Review of Randomized Controlled Trials from Long-Term Care with Potential Use in Critical Care.
Anderson AR; Deng J; Anthony RS; Atalla SA; Monroe TB
Crit Care Nurs Clin North Am; 2017 Dec; 29(4):519-537. PubMed ID: 29107312
[TBL] [Abstract][Full Text] [Related]
15. Translational Value of the Transdermal Administration of Bergamot Essential Oil and of Its Fractions.
Scuteri D; Rombolà L; Crudo M; Watanabe C; Mizoguchi H; Sakurada S; Hamamura K; Sakurada T; Morrone LA; Tonin P; Bagetta G; Corasaniti MT
Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631592
[TBL] [Abstract][Full Text] [Related]
16. Implication of limonene and linalyl acetate in cytotoxicity induced by bergamot essential oil in human neuroblastoma cells.
Russo R; Ciociaro A; Berliocchi L; Cassiano MG; Rombolà L; Ragusa S; Bagetta G; Blandini F; Corasaniti MT
Fitoterapia; 2013 Sep; 89():48-57. PubMed ID: 23707744
[TBL] [Abstract][Full Text] [Related]
17. Behavioral Effects of Continuously Administered Bergamot Essential Oil on Mice With Partial Sciatic Nerve Ligation.
Hamamura K; Katsuyama S; Komatsu T; Scuteri D; Bagetta G; Aritake K; Sakurada T
Front Pharmacol; 2020; 11():1310. PubMed ID: 32973528
[TBL] [Abstract][Full Text] [Related]
18. Bergamot Essential Oil: A Method for Introducing It in Solid Dosage Forms.
Zambito Y; Piras AM; Fabiano A
Foods; 2022 Nov; 11(23):. PubMed ID: 36496668
[TBL] [Abstract][Full Text] [Related]
19. Intraplantar injection of bergamot essential oil into the mouse hindpaw: effects on capsaicin-induced nociceptive behaviors.
Sakurada T; Kuwahata H; Katsuyama S; Komatsu T; Morrone LA; Corasaniti MT; Bagetta G; Sakurada S
Int Rev Neurobiol; 2009; 85():237-48. PubMed ID: 19607974
[TBL] [Abstract][Full Text] [Related]
20. Peripherally injected linalool and bergamot essential oil attenuate mechanical allodynia via inhibiting spinal ERK phosphorylation.
Kuwahata H; Komatsu T; Katsuyama S; Corasaniti MT; Bagetta G; Sakurada S; Sakurada T; Takahama K
Pharmacol Biochem Behav; 2013 Feb; 103(4):735-41. PubMed ID: 23159543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
